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What Prescription Drugs Do People 
Misuse?
• Addictive drugs: (eg opiates, benzodiazepines,) 
– Often with  physical withdrawal syndrome
• Non-addictive drugs may still be abused: 
– for their effects eg tricyclics
– for regular self-medication e.g. antihistamine for sleep
– in a compulsive way eg laxatives
– to enhance the effects of other drugs e.g. SSRI’s
Who misuses Prescription 
Drugs?
Patients:
•Older adults 
•Adolescents
•Women 
Healthcare 
professionals:
• Doctors 
• Nurses 
• Pharmacists 
• Dentists 
• Anaesthetists 
• Veterinary surgeons
Evidence of Misuse
• In 2007, 20% of all people in USA age 12 and 
up - had used prescription drugs non-medically 
at least once in their lives
• Among young adults, age 18 to 25, 30% had 
used these drugs non-medically at least once
• The number of people misusing pain relievers 
climbed from about 0.1% of the population in the 
mid-80’s to 13% in 2007
(US National Survey on Drug Use & Health, NSDUH)
What Harm?
• Less severe than illicit drugs:
– Ingested orally
– No toxic impurities
– Known strength
– Legally obtained – less risk violence or Crim Justice 
involvement
• Potential harms:
– From other ingredients
• Eg Paracetamol OD
– From the drug itself
• Eg Grand mal seizure in tramadol OD
Detection of Prescription Drug Abuse
• Duty to monitor patients’ use of drugs that may 
indicate abuse or increasing tolerance :
– rapid increases in the amount of a medication 
needed/frequent lost scripts
– Frequent requests for refills or running out before due
– “doctor shopping”
• Aim for a BALANCE – Healthcare professionals 
should not avoid prescribing or administering 
strong CNS depressants and painkillers etc, if they 
are needed for good clinical reasons
Recommendations of APPDMG 
Concerning GPs 
• “That, when GPs prescribe drugs known to have 
the potential to cause physical dependence or 
addiction, they must explain these potential risks 
to the patient” (Rec. 2.2, p.53)
• “That, when GPs prescribe addictive drugs such 
as opiates, benzos & related classes of drugs, 
they should set up procedures to monitor the 
patient. … The practice of repeat prescription 
without review for these drugs must end” (Rec. 
3.3, p.55)
Prevention & Monitoring
• Careful use of repeats
• Make use of pharmacists (local & PCT)
• Surveillance (run regular in house reports)
Assessment
• No rush – not dangerous to wait till complete picture obtained (cf illicit
opiates)
• Other drugs– esp benzo’s and alcohol
• Diary
– At least 2 weeks 
– Also acts as good assessment of motivation to stop 
– Look for: 
• Daily use (as opposed to binging)
• Routines
• Triggers
• Aspects of dependency:
– Drug seeking behaviour
– Lack of interest in/prioritising over other activities
– Physical withdrawals
• Mental health assessment - underlying anxiety, depression, chronic 
low self esteem, social phobia, marital difficulties, unresolved grief etc 
• Pain – remember the patient may actually need these drugs for analgesia!
Harm minimisation interventions
• Information
– Risk of OD; death in opiates, seizure in tramadol
– Risk of S/E’s: hepatotoxicity in paracetamol, 
gastritis in ibuprofen
• Prescribing for harm minimisation:
– Convert co-codamol/Nurofen plus to plain 
codeine
– Increase frequency of dispensing
Reduction/detoxification interventions
• Same drug - self reduction plan vs prescribing
– Advantages
• Familiar
– Potential problems:
• Toxicology unhelpful – easy to use on top
• No blockade
• Substitute: eg slow release DHC/ buprenorphine, MST/ Methadone
– Advantages
• Blockade with buprenorphine
• Generally longer acting
• Potential for supervision of dose if indicated
• Differentiable on toxicology
– Problems
• Conversion somewhat uncertain
• Unfamiliar drug to patient
• Stigma
• Buprenorphine may precipitate withdrawals
Prescribing
• Conversion to substitute (if approp) – no firm 
guidelines
• Aim for stability first so no extra use
• Make reduction plan at outset
• Be aware blue scripts/supervised doses can 
stigmatise
– Consider trial period weekly/twice weekly 
scripts
• Be prepared to delay a step or two 
– Eg if withdrawals bad or stressful life events
• Pain may cause need to stop if reach level below 
which pain becomes intolerable
Support with….
• Good therapeutic relationship
• Regular diary keeping and face to face review
• Management of associated problems:
– Mental health issues
– Pain
• Peer support (even if remote eg codeinefree.me)
• Wraparound support 
– Education, training, employment, housing
– possibly via community drugs services
• Time, patience and hope…
Eg. Pete…
• Pneumonia
• Rx Co-codamol 30/500
• Overuse
• Assessment
• Trial of codeine
• Trial of DHC S/R…home visit


Eg. Pete…
• Stable methadone script
Key Messages
• Prevent
• Spot
• Engage
• Review
• Training
